Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcrition profiling of Langerhans Cell Histiocytosis to determine cell specific gene expression


ABSTRACT: Langerhans-cell histiocytosis (LCH) is characterized by heterogeneous lesions containing CD207+ Langerhans cells (LCs) and lymphocytes. In this study, we isolated CD207+ cells and CD3+ T cells from LCH lesions to determine cell-specific gene expression. Compared to control epidermal CD207+ cells, the LCH CD207+ cells yielded 2113 differentially-expressed genes (FDR<0.01). Surprisingly, expression of many genes previously associated with LCH, including cell-cycle regulators, pro-inflammatory cytokines and chemokines were not significantly different from control LCs in our study. However, several novel genes whose products activate and recruit T cells to sites of inflammation, including SPP1 (osteopontin), were highly over-expressed in LCH CD207+ cells. Furthermore, several genes associated with immature myeloid dendritic cells were over-expressed in LCH CD207+ cells. Compared to the peripheral CD3+ cells from LCH patients, the LCH lesion CD3+ cells yielded only 162 differentially-regulated genes (FDR<0.01), and the expression profile of the LCH lesion CD3+ cells was consistent with an activated regulatory T cell phenotype with increased expression of FOXP3, CTLA4 as well as SPP1. Based on these results, we propose a new model of LCH pathogenesis in which lesions do not arise from epidermal Langerhans cells, but from accumulation of bone-marrow derived immature myeloid dendritic cells that recruit activated lymphocytes. Cell-specific gene expression from LCH biopsy specimens was evaluated by comparing hybridization signal from amplified cDNA on Affymetrix gene chips (U133A Plus 2.0) (Table1). Three sets of comparisons were performed: 1) Thirteen LCH CD207+ samples were compared to 12 control skin LCH CD207+ samples. 2) Seven LCH lesion CD3+ samples were compared to 7 peripheral blood CD3+ samples from the same patients. 3) Twelve LCH lesion CD3+ samples were compared to 4 pooled control tonsil CD3+ samples (5 individual tonsil CD3+ samples/pool).

ORGANISM(S): Homo sapiens

SUBMITTER: M Hicks 

PROVIDER: E-GEOD-16395 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Allen Carl E CE   Li Liunan L   Peters Tricia L TL   Leung Hon-Chiu Eastwood HC   Yu Alexander A   Man Tsz-Kwong TK   Gurusiddappa Sivashankarappa S   Phillips Michelle T MT   Hicks M John MJ   Gaikwad Amos A   Merad Miriam M   McClain Kenneth L KL  

Journal of immunology (Baltimore, Md. : 1950) 20100310 8


Langerhans cell histiocytosis (LCH) is a rare disease characterized by heterogeneous lesions containing CD207(+) Langerhans cells (LCs) and lymphocytes that can arise in almost any tissue and cause significant morbidity and mortality. After decades of research, the cause of LCH remains speculative. A prevailing model suggests that LCH arises from malignant transformation and metastasis of epidermal LCs. In this study, CD207(+) cells and CD3(+) T cells were isolated from LCH lesions to determine  ...[more]

Similar Datasets

2010-03-15 | GSE16395 | GEO
2020-01-21 | GSE122476 | GEO
2020-01-21 | GSE122674 | GEO
2012-10-24 | E-GEOD-35340 | biostudies-arrayexpress
2017-12-20 | GSE108251 | GEO
2012-10-24 | GSE35340 | GEO
2024-12-05 | GSE270891 | GEO
| PRJNA505993 | ENA
| PRJNA505325 | ENA
2013-10-18 | E-GEOD-49085 | biostudies-arrayexpress